UnitedHealth Calls 2026 the Bottom for Medicaid Margins - UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (UNH) raised its 2026 adjusted earnings outlook to $20.50 per share, but shares fell 0.7% to $375.86. Q3 revenue was $112.7B, operating earnings $6.6B, and adjusted earnings $4.69 per share. Medical-cost ratio improved to 88.4% from 89.9% YoY, according to MarketWatch. The stock trades at 18.3x the minimum adjusted earnings forecast.

UnitedHealth reported a 75% profit increase to $4.1B in Q3, exceeding forecasts, but revenue fell 2.2% to $87.1B. The company reduced medical costs by $3B and covered 2.5M fewer people. Stock initially rose 4% but later fell due to investor concerns about future growth and reliance on reserve releases. UnitedHealth raised its annual earnings forecast to at least $20.50 per share.

UnitedHealth reported Q3 revenue of $112.7B, down slightly YoY, but earnings from operations rose to $6.6B. CEO Steve Hemsley highlighted AI's role in reducing chart review time by 33% for clinicians and appeal cycle times by 26%. The company is also introducing AI-powered plan recommendations for Medicare Advantage. Optum Health saw a 27% YoY surge in online self-scheduling and a 10% increase in home health visits.

UnitedHealth Group reported Q3 2026 revenue of $112.7B and operating earnings of $6.6B, raising its full-year earnings outlook to at least $19.50 per share. The company cited improved profitability across UnitedHealthcare and Optum, with better medical cost management and operating efficiencies. UnitedHealthcare served 48.3M people, while Optum generated $66.9B in revenue and $3.73B in operating earnings.

UnitedHealth Group (UNH) reported Q3 2026 revenue of $113 billion and adjusted EPS of $4.69, up from $2.92 a year ago. The company raised its full-year adjusted EPS guidance to at least $20.50. Key highlights include a 30% reduction in prior authorizations, AI-driven efficiencies, and Medicare Advantage margin expectations near the top of the 2% to 4% range. Challenges include elevated commercial medical trends and negative Medicaid margins.

UnitedHealth Group (UNH) reported Q3 2026 revenue of $113B and adjusted EPS of $4.69, reaffirming its full-year EPS guidance of at least $20.50. The company offers a 2.41% dividend yield with a 58% payout ratio and a 10.9% 3-year dividend growth rate. UNH's GF Score is 81/100, indicating strong fundamentals, particularly in profitability and momentum. Insider activity shows net selling, while 35 premium gurus hold the stock, with mixed sentiment among institutional investors.